Verrica Pharmaceuticals 2024 Company Overview - YCANTH Molluscum Contagiosum

Verrica Pharmaceuticals presents company overview highlighting the FDA approval of YCANTH™, the first FDA-approved treatment for molluscum contagiosum. The presentation covers Verrica's business strategy, clinical programs, and commercial launch plans for its lead product candidate.